A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment. [electronic resource]
- Cancer letters 05 2017
- 16-21 p. digital
Publication Type: Journal Article
1872-7980
10.1016/j.canlet.2017.01.042 doi
17-Hydroxysteroid Dehydrogenases--antagonists & inhibitors 3-Hydroxyacyl CoA Dehydrogenases--antagonists & inhibitors Adenocarcinoma--drug therapy Animals Antineoplastic Agents--chemistry Antipsychotic Agents--chemistry Bacteriophage T7--genetics Cell Line, Tumor Cell Proliferation--drug effects Dose-Response Relationship, Drug Drosophila melanogaster--drug effects Drug Compounding Drug Repositioning--methods Enzyme Inhibitors--chemistry Gene Library Genomics--methods Humans Linoleic Acids, Conjugated--chemistry Male Mice, Nude Molecular Docking Simulation Molecular Targeted Therapy Prostatic Neoplasms--drug therapy Protein Conformation Risperidone--chemistry Structure-Activity Relationship Time Factors Tumor Burden--drug effects Xenograft Model Antitumor Assays